Literature DB >> 33447338

Detection of high-risk human papillomavirus (HPV) by the novel AmpFire isothermal HPV assay among pregnant women in Pemba Island, Tanzania.

Naomi Christine Angela Juliana1, Mohamed Hamad Juma2, Roel Heijmans3, Sander Ouburg3, Said Mohammed Ali2, Aishwarya Singh Chauhan4, Amanhi Biobank Pemba2, Sunil Sazawal2,4, Servaas Antonie Morré1,3, Saikat Deb2,4, Elena Ambrosino1.   

Abstract

INTRODUCTION: human papillomavirus (HPV) is the most common sexually transmitted virus in the world. Prevalence of infection differs, with highest rates reported in sub-Saharan African, including the country of Tanzania. In pregnancy, the hormonal changes and immune changes seem to facilitate HPV persistence, increasing the cancer risk and the risk of vertical transmission towards the placenta and the fetus. The burden of HPV infection is still high despite multiple screening and detection test available. The AmpFire® HPV assay is a novel nucleic acid isothermal amplification with real-time fluorescence detection assay that can test simultaneously 15 high-risk HPV. This nested cohort study aims to contribute evidence on the prevalence of HPV infection and persistence across two time points among pregnant women in Pemba island, Tanzania.
METHODS: vaginal swabs that were previously collected during pregnancy were stored in eNAT buffer (n1=385 and n2=187) and were tested with AmpFire® screening assay, for simultaneous detection of the HPV 16, 18 and other high-risk HPV genotypes 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66 and 68.
RESULTS: the AmpFire® HPV assay detected an 11% and 6% high-risk HPV prevalence at the two time points among pregnant women in Pemba island, consecutively. For the 133 women whose samples were tested at both time points, the persistence rate of high-risk HPV was 64%.
CONCLUSION: novel isothermal HPV assay, such as the AmpFire®, might be feasible to use in low-income regions. Copyright: Naomi Christine Angela Juliana et al.

Entities:  

Keywords:  AmpFire HPV; HPV infection; HPV persistence; isothermal; pregnancy; sub-Saharan Africa

Mesh:

Year:  2020        PMID: 33447338      PMCID: PMC7778224          DOI: 10.11604/pamj.2020.37.183.23367

Source DB:  PubMed          Journal:  Pan Afr Med J


  24 in total

1.  Longitudinal study of the effects of pregnancy and other factors on detection of HPV.

Authors:  J Chang-Claude; A Schneider; E Smith; M Blettner; J Wahrendorf; L Turek
Journal:  Gynecol Oncol       Date:  1996-03       Impact factor: 5.482

Review 2.  A review of the FDA-approved molecular testing platforms for human papillomavirus.

Authors:  Katrina L Salazar; Daniel J Duhon; Randall Olsen; Michael Thrall
Journal:  J Am Soc Cytopathol       Date:  2019-06-13

3.  Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study.

Authors:  Myassa Dartell; Vibeke Rasch; Crispin Kahesa; Julius Mwaiselage; Twalib Ngoma; Jette Junge; Anne Gernow; Sussie Funch Ejlersen; Christian Munk; Thomas Iftner; Susanne Krüger Kjaer
Journal:  Sex Transm Dis       Date:  2012-03       Impact factor: 2.830

4.  Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period.

Authors:  K H Fife; B P Katz; E J Brizendine; D R Brown
Journal:  Am J Obstet Gynecol       Date:  1999-05       Impact factor: 8.661

5.  Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity.

Authors:  Joke A M Dols; Douwe Molenaar; Jannie J van der Helm; Martien P M Caspers; Alie de Kat Angelino-Bart; Frank H J Schuren; Adrianus G C L Speksnijder; Hans V Westerhoff; Jan Hendrik Richardus; Mathilde E Boon; Gregor Reid; Henry J C de Vries; Remco Kort
Journal:  BMC Infect Dis       Date:  2016-04-23       Impact factor: 3.090

6.  High prevalence of human papillomaviruses in Ghanaian pregnant women.

Authors:  Marco H Schulze; Fabian M Völker; Raimond Lugert; Paul Cooper; Kai Hasenclever; Uwe Groß; Herbert Pfister; Steffi Silling
Journal:  Med Microbiol Immunol       Date:  2016-09-06       Impact factor: 3.402

7.  Human Papillomavirus (HPV) Infection in Early Pregnancy: Prevalence and Implications.

Authors:  Deeksha Pandey; Vani Solleti; Gazal Jain; Anwesha Das; Kabekkodu Shama Prasada; Shobha Acharya; Kapaettu Satyamoorthy
Journal:  Infect Dis Obstet Gynecol       Date:  2019-03-24

8.  Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, Chlamydia trachomatis, and human papilloma virus.

Authors:  Jelena Malogajski; Ivan Brankovic; Stephan P Verweij; Elena Ambrosino; Michiel A van Agtmael; Angela Brand; Sander Ouburg; Servaas A Morré
Journal:  Biomed Res Int       Date:  2013-05-23       Impact factor: 3.411

9.  High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum.

Authors:  M A E Nobbenhuis; T J M Helmerhorst; A J C van den Brule; L Rozendaal; P D Bezemer; F J Voorhorst; C J L M Meijer
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

10.  Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study.

Authors: 
Journal:  Lancet Glob Health       Date:  2018-10-22       Impact factor: 26.763

View more
  1 in total

1.  The Vaginal Microbiota Composition and Genital Infections during and after Pregnancy among Women in Pemba Island, Tanzania.

Authors:  Naomi C A Juliana; Saikat Deb; Mohamed H Juma; Linda Poort; Andries E Budding; Abdalla Mbarouk; Said M Ali; Sander Ouburg; Servaas A Morré; Sunil Sazawal; Elena Ambrosino
Journal:  Microorganisms       Date:  2022-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.